ResMed Raises Quarterly Dividend 10% to $0.66

ResMed Inc. (NYSE: RMD) raised its quarterly dividend by 10%, increasing the payment to $0.66 per share from $0.60. The healthcare company’s shares traded ex-dividend on August 20, 2026.

At the new quarterly rate, ResMed’s annualized dividend is $2.64 per share. Based on a share price of $231.52, that equates to a forward annual yield of 1.14%.

The increase extends ResMed’s dividend-growth streak to 13 consecutive years. The company has not previously cut its dividend in the period covered by the supplied data, while its dividend-safety assessment stands at 87 out of 100, equivalent to an A grade.

Business momentum supports the increase

ResMed announced the higher payout alongside its fiscal fourth-quarter results. Quarterly revenue rose 9% to approximately $1.5 billion, reflecting demand across sleep devices, masks, accessories and software. For the full fiscal year, revenue increased 10% to $5.7 billion, while operating cash flow reached $1.8 billion, according to the company’s earnings release.

Chairman and Chief Executive Mick Farrell said the year’s cash generation allowed ResMed to invest in innovation, strengthen its market position and return capital to shareholders. The company also cited continued momentum in its global business and sustained demand for its products.

ResMed primarily develops connected devices, masks and digital health tools used in the treatment and management of sleep and respiratory disorders. Its annual filing identifies two operating segments: Sleep and Breathing Health and Residential Care Software. The latter provides business-management software for residential-care providers, according to ResMed’s fiscal 2026 Form 10-K.

What it means for income investors

The increase adds $0.06 per share to each quarterly payment and $0.24 per share to the annualized dividend. ResMed’s 1.14% forward yield remains modest, making the event more notable for the continuation of its 13-year growth record than for a high current income rate. The A safety grade and 87 safety score indicate that the dividend is assessed as comparatively well supported, although future payments remain subject to board approval and business conditions.